Skip to content
Review Open access

Cognitive Effects of Prenatal Exposure to SSRIs in Children: A Systematic Review and Meta‐Analysis

Jan 2026 · International Journal of Pediatrics · Vol 2026 · 0 citations · 15 references
Medicine

TL;DR

Current evidence does not support a clinically meaningful impact of prenatal SSRI exposure on early cognitive, language, or psychomotor development.

Abstract

Background Depression and anxiety occur in about 10% of pregnancies. Selective serotonin reuptake inhibitors (SSRIs) are often prescribed, but their potential effects on fetal neurodevelopment remain uncertain. Because serotonin influences brain maturation, prenatal SSRI exposure may affect later cognition, language, or motor function. Methods This systematic review and meta‐analysis evaluated whether prenatal SSRI exposure is associated with differences in child cognitive, language, or psychomotor development. PubMed and Scopus were searched through June 2025 for cohort, case‐control, or randomized studies reporting standardized neurodevelopmental outcomes in children (0–18 years) with documented in utero SSRI exposure compared with unexposed controls. Two reviewers independently screened studies, extracted data, and assessed bias (Newcastle–Ottawa Scale; RoB‐2). Random‐effects meta‐analyses estimated standardized mean differences (SMDs) with 95% confidence intervals (CIs). Results Of 250 records identified, 17 studies met inclusion criteria, and 9 contributed to meta‐analysis. For general cognition, pooled SMD = −0.20 (95% CI −0.50 to 0.10) showed no significant difference between groups. Sensitivity analyses restricted to SSRI‐only cohorts and Bayley‐specific instruments yielded similar findings. Secondary outcomes also showed no differences: receptive language (SMD = 0.04; 95% CI −0.16 to 0.23), expressive language (SMD = −0.17; 95% CI −0.40 to 0.06), and psychomotor development (SMD = −0.18; 95% CI −0.67 to 0.31). Conclusions Current evidence does not support a clinically meaningful impact of prenatal SSRI exposure on early cognitive, language, or psychomotor development. Observed effects were small, imprecise, and diminished when analyses were limited to SSRI‐only cohorts and harmonized outcome measures.

Read PDF

Similar papers

Review Open access Oct 2026

Pregnancy and Offspring Outcomes After Prenatal Stimulant or Atomoxetine Exposure: A Systematic Review and Meta-analysis.

OBJECTIVE To evaluate associations of prenatal exposure to stimulants and atomoxetine for attention-deficit/hyperactivity disorder with pregnancy, congenital, perinatal, and neurodevelopmental outcomes. DATA SOURCES PubMed, Embase, Cochrane Library, and Web of Science were searched from inception to March 2026. Proto...

Rinat Komargodski, Abeer Tillawe, Maya Berlin et al. · 0 citations
Review Oct 2026

Comparative effects of non-pharmacological intervention categories on cognitive domains in children with autism spectrum disorder: A systematic review and network meta-analysis of randomized controlled trials.

This systematic review and network meta-analysis aimed to compare the effects of non-pharmacological intervention categories on attention, working memory, comprehensive executive function, and social-emotional cognition in children with autism spectrum disorder. Five databases were searched for randomized controlled tr...

Miao-Wen Zheng, Shu-Ning Liu, Yan-Qing Wei et al. · 0 citations
Review Open access Sep 2026

Testing Claimed Associations of Prenatal Acetaminophen with Neurodevelopmental Disorders: Re-analysis Using Bias-Correction Methods

The claim of "strong evidence" for an acetaminophen-neurodevelopmental-disorder association was not supported by this reanalysis, as a modest ADHD association persisted, while ASD and other-NDD estimates moved toward the null.

A. Grover, J. Reis-Pardal, R. Ellis et al. · 0 citations
Review Open access Sep 2026

Long-Term Prenatal Systemic Glucocorticoid Exposure and Offspring Neurodevelopmental and Neuropsychiatric Outcomes: A Systematic Review.

Prenatal glucocorticoid use was associated with modestly increased risks of ASD and ADHD, however, residual confounding by maternal disease severity remained a major limitation and a specific medication-related effect could not be conclusively established.

Guang-Nan Mei, Jin Gan, Ya-Fang Xia et al. · 0 citations
Review Oct 2026

Impact of prenatal cannabis exposure on offspring brain structure and function: a systematic review of MRI studies.

AIM Cannabis use during pregnancy has increased, raising concerns about potential effects on offspring brain development. The objective of this systematic review was to evaluate MRI-based evidence on the association between prenatal cannabis exposure (PCE) and offspring brain development across structural, diffusion, r...

Elaheh Karimi, Arash Safari Sabet, M. Terplan et al. · 0 citations
Review Open access Sep 2026

Sex-based Differences in the Efficacy and Tolerability of Selective Serotonin Reuptake Inhibitors in Adults with Major Depressive Disorder: A Systematic Review and Meta-analysis

Purpose of the Review: Sex-based differences in antidepressant outcomes may influence treatment decisions in major depressive disorder (MDD). This systematic review and meta-analysis evaluated sex-based differences in the efficacy and tolerability of selective serotonin reuptake inhibitors (SSRIs) in adults with MDD. C...

Amrita Kumari Pandey, Abhinav Tiwary, F. Khan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.